Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes

By afschroeder • August 19, 2025

Husain M, Butler C, Fan AM, Halnon NJ, Reardon LC, Alejos JC. Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes. JHLT Open. 2025 Jul 17;10:100346. doi: 10.1016/j.jhlto.2025.100346. PMID: 40822087; PMCID: PMC12354783.

Tags: allosensitization, Cardiology/Epi, complex congenital heart disease, daratumumab, desensitization, Pediatric heart transplant, Publications

Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial

Budoff MJ, Bhandari M, Iskander B, Ghanem AK, Kinninger A, Stark J, Garikapati V, Chilukuri S, Hankil V, Krishnan S, Punnanithinont N, Ichikawa K, Kambalapalli[...]

Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor[...]

Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis

Chen G, Chung T, Liu Z, Li YR, Scott K, Zhao X, Carol J, Park S, Zhou Y, Kim WJ, Ge X, Colby GP, Li[...]